Publicacions (46) Publicacions de Marta Rodríguez González

2024

  1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  2. Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma

    Scientific Reports, Vol. 14, Núm. 1

  3. LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma

    The British journal of dermatology, Vol. 190, Núm. 6, pp. 876-884

  4. Survival among treated tongue cancer patients: a single-center experience

    Discover Oncology, Vol. 15, Núm. 1

2023

  1. Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  2. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets

    American Journal of Hematology

  3. Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

    Cancers, Vol. 15, Núm. 17

  4. NanoString analysis of mycosis fungoides reveals individual molecular identity

    British Journal of Dermatology

  5. The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients

    Diagnostics, Vol. 13, Núm. 14

  6. Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils

    Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 502-509

  7. siRNA screening reveals that SNAP29 contributes to exosome release

    Cellular and Molecular Life Sciences, Vol. 80, Núm. 7

2022

  1. A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

    Journal of Visualized Experiments, Vol. 2022, Núm. 187

  2. Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups

    Cancers, Vol. 14, Núm. 17

  3. PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression

    Journal of Investigative Dermatology, Vol. 142, Núm. 5, pp. 1391-1400.e15

  4. iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers

    WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 13, Núm. 7, pp. 616-629

2021

  1. Cómo mejorar la precisión de los diagnósticos I y III del Sistema Bethesda

    Revista ORL, Vol. 12, Vol. 4, pp. 313-323

  2. Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy

    Hemato, Vol. 2, Núm. 2, pp. 281-304

  3. Genetic complexity impacts the clinical outcome of follicular lymphoma patients

    Blood Cancer Journal

  4. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death

    Blood, Vol. 137, Núm. 24, pp. 3351-3364

  5. Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers

    Blood Advances, Vol. 5, Núm. 24, pp. 5588-5598